Prohibition Partners LIVE Announces ProCapital, a Partnership with MAZAKALI


Ryan Allway

April 30th, 2020

News


Prohibition Partners LIVE, in partnership with MAZAKALI, a global digital investment firm, is delighted to announce the launch of ProCapital, an exclusive investment-focused two day interactive forum showcasing investment opportunities across the international plant-based medicines (PBM) space that includes cannabis and psychedelics.

On June 22-23, investors, operators, and entrepreneurs from all over the world will gather together on one digital platform to connect with the brightest and most innovative businesses operating in these rapidly developing markets. ProCapital offers operators the opportunity to attract capital and investors the ability to make real-time investments and obtain guidance from those at the cutting edge of the cannabis and psychedelics industries.

Weathering the storm

Inside the US cannabis industry, the coronavirus pandemic has seen many recently ‘illegal’ cannabis businesses suddenly be deemed ‘essential’. The cannabis industry has been highlighted as an industry that can help repair the economic impact of the pandemic as geographies begin to re-open. With the IMF and the UN predicting that a global recession is likely to follow in the wake of the pandemic, the potential for the cannabis industry to provide tax revenue along with job growth will appear increasingly attractive to those governments who have yet to establish their own legal cannabis markets.

While the coronavirus pandemic has driven great uncertainty in the global markets, the cannabis and psychedelics sectors are continuing to drive investment. Recently, the German biotech and psychedelics company ATAI, backed by Peter Thiel, successfully raised US$24 million from its investors, with the psychedelics firm MindMed raising US$24.2 million before moving to go public in early-March. Investors are continuing to support these private companies while volatility in the public equity markets has remained at elevated levels throughout this pandemic.

“It is a turbulent time for the industry. Severe limitations are being placed on travel, mobility and the natural operations of the cannabis supply chain. However, we continue to learn, educate and innovate in a bid to deliver real value to delegates from every corner of the globe. With uncertainty brewing across the market we are bringing together the global industry to help provide clarity. That is why we are delighted to be working with MAZAKALI, who have demonstrated clear market leadership in the US investment landscape.“ explained Stephen Murphy, Group Managing Director of Prohibition Partners after announcing the partnership.

“Against a backdrop of industry consolidation, physical distancing has also promoted exploratory travel across vast, virtual bridges of cooperation. ProCapital is born of the idea that synergistic partnerships accelerate efficiency gains, and that quality global education, networking and investment will fuel this classic emerging market through its next growth stage. Sustainable value based on core fundamentals has replaced temporary euphoria-driven pricing, a return of rationale welcome to investors exploring what might prove to be the best performing asset class in the decade ahead.” – said Sumit Mehta, Founder and CEO of MAZAKALI.

Pivotal timing for the US cannabis movement

ProCapital will showcase industry leaders from the US at what may prove to be a pivotal time for the US cannabis industry. The United States is already home to the world’s largest legal cannabis market, California, and yet the plant remains illegal at the federal level. As elections approach, polls indicate that over two-thirds of Americans would support cannabis legalization.

The two-day ProCapital stream will take place during Prohibition Partners LIVE, on 22-23 June, 2020. Powered by MAZAKALI’s Digital Capital Investment Platform, ProCapital will offer curated opportunities and broker/dealer supported investment flow within the plant-based medicine (PBM) space. Licensed Investment Advisors will provide investors with the education and tools needed to build and implement optimal investment portfolios across cannabis and psychedelics.

Attendees can expect to hear perspectives from leading investors, politicians and cultural leaders. Delegates will have the opportunity to ask questions, schedule meetings, and make direct investments into curated and broker/dealer approved private companies through the MAZAKALI Digital Capital Portal.

Super early-bird tickets for Prohibition Partners LIVE are on sale now. To view the full agenda for ProCapital, as well as the other Prohibition Partners LIVE event streams, click here.

Apply to pitch at the summer’s most influential global cannabis and psychedelics event:

  • CLICK: Set up an “Issuer Account” on the MAZAKALI Digital Capital Portal
  • SELECT: Pitch @ Prohibition Partners LIVE application
  • BEGIN: Submit application online by May 15th deadline
  • RECEIVE: Your MAZAKALI Investment Committee decision within 5 business days

Headquartered in San Francisco, MAZAKALI offers its Digital Capital Investment Platform to the global plant-based medicine (PBM) complex. Registered Investment Advisors customize investment portfolios via MAZAKALI’s Outsourced Cannabis Investment Officer (OCIO) service, and licensed Investment Bankers help operators with capital and M&A services. MAZAKALI’s leadership team began putting PBM capital to work in 2014 and brings over 150 years of financial, strategic, legal, compliance and international business experience to clients across the global hemp, non-hemp cannabis and psychedelics industries. The MAZAKALI GreenPaper® has gained authority through knowledge on deep trends in the industry that matter to investors and operators alike. Securities are offered via a licensed Broker/Dealer.

Prohibition Partners LIVE connects you to the global cannabis industry from your own home. On June 22-23, we are bringing together delegates from every corner of the globe to help share knowledge, gain insight and shape the future of cannabis. Access all of our unique and engaging conferences this year across five virtual stages – Cannabis Europa, Cannabis Americana, Cannabis Oceania, PSYCH and ProCapital.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading